| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Charles Farkas is Director at CNMD. From April 2015 to June 2026, the filings on record show 12 open-market purchases and 2 sales. Charles Farkas's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $733K at current prices.
The CNMD filings lean toward selling, a net 3,032 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2016 | CNMD Conmed Corp | Director | Buy | 332 | $42.18 | $14,004.72 | +8.9% | |
| Oct 1, 2015 | CNMD Conmed Corp | Director | Buy | 292 | $47.74 | $13,939.08 | +8.5% | |
| Jul 2, 2015 | CNMD Conmed Corp | Director | Buy | 205 | $58.66 | $12,024.32 | +6.3% | |
| Apr 1, 2015 | CNMD Conmed Corp | Director | Buy | 235 | $50.74 | $11,924.70 | New |